GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (NSE:MEDICAMEQ) » Definitions » Net Income (Discontinued Operations)

Medicamen Biotech (NSE:MEDICAMEQ) Net Income (Discontinued Operations) : ₹0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medicamen Biotech Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. Medicamen Biotech's Net Income (Discontinued Operations) for the three months ended in Sep. 2024 was ₹0 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil.

Medicamen Biotech Net Income (Discontinued Operations) Historical Data

The historical data trend for Medicamen Biotech's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Biotech Net Income (Discontinued Operations) Chart

Medicamen Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income (Discontinued Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medicamen Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income (Discontinued Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medicamen Biotech Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Biotech Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of Medicamen Biotech's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicamen Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (NSE:MEDICAMEQ) » Definitions » Net Income (Discontinued Operations)
Comparable Companies
BOM:524470 BOM:543998 BOM:543329 BOM:506197 BOM:540737 BOM:506260 NSE:BETA BOM:540937 NSE:SAKAR BOM:541400 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
531146:India
Address
1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019
Website
https://www.medicamen.com
Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.

Medicamen Biotech Headlines

No Headlines